CRISPR gene editing takes on rare immunodeficiency disorder

Posted by on January 12, 2017 3:07 pm
Categories: Science

Researchers have harnessed the CRISPR-Cas9 technology to correct mutations in the blood stem cells of patients with a rare immunodeficiency disorder; the engineered cells successfully engrafted in mice for up to five months.

Leave a Reply

Your email address will not be published.